DeLarme Wealth Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$208K Buy
180
+1
+0.6% +$1.18K 0.12% 71
2026
Q2
$215K Buy
+179
New +$183K 0.12% 65

Other funds holding LLY

DeLarme Wealth Management's LLY Position: Q3 2026 in Review

DeLarme Wealth Management increased its Eli Lilly (LLY) stake by 0.56% in Q3 2026, buying an estimated $1.18K and bringing the position to 180 shares worth $208K. The position accounts for 0.12% of the portfolio, ranked #71.

DeLarme Wealth Management first reported a position in LLY in Q2 2026 and has held it in 2 quarters since. The position peaked at $215K in Q2 2026. 4,616 funds tracked by Wall St. Rank hold LLY as of Q3 2026.

  • DeLarme Wealth Management held 180 shares of Eli Lilly worth $208K as of Q3 2026.
  • DeLarme Wealth Management bought 1 Eli Lilly share in Q3 2026, an estimated $1.18K.
  • Eli Lilly made up 0.12% of DeLarme Wealth Management's portfolio in Q3 2026, its #71 holding.
  • DeLarme Wealth Management first reported a position in Eli Lilly in Q2 2026 and has held it in 2 quarters since.
  • DeLarme Wealth Management's Eli Lilly position peaked at $215K in Q2 2026.
  • 4,616 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2026.

Based on DeLarme Wealth Management's 13F filing for Q3 2026, filed 30 Oct 2026.